MetaVia Inc. (MTVA) income statement
MTVANasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.07+0.01 (+0.94%)
Close on Nov 19, 2026Market cap $7.05MP/E –Yield –
MetaVia Inc. financial ratios
See a number that looks wrong?
Close on Nov 19, 2026Market cap $7.05MP/E –Yield –
See a number that looks wrong?
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Returns on capital | |||||||||||||
| Return on equity | -195.6% | -224.2% | -64.9% | -76.9% | -140.2% | -304.5% | 4,288.1% | 356.5% | -323.5% | -362.4% | 202.1% | 80.5% | – |
| Return on assets | -94.8% | -141.3% | -44.3% | -55.5% | -110.1% | -233.4% | -233.1% | -136.0% | -152.7% | -99.8% | -201.1% | – | – |
| Return on tangible assets | -94.8% | -141.3% | -44.3% | -55.5% | -110.1% | -233.4% | -233.1% | -136.0% | -152.7% | -99.8% | -201.1% | – | – |
| Return on capital employed | -203.6% | -232.2% | -82.4% | -107.9% | -139.6% | -302.3% | -252.4% | -190.9% | -199.2% | -181.4% | 182.4% | – | – |
| NOPAT | -$10.83M | -$22.76M | -$12.55M | -$15.51M | -$12.09M | -$23.48M | -$15.94M | -$12.23M | -$26.17M | -$11.61M | -$6.38M | -$210.14K | – |
| Cash flow quality | |||||||||||||
| OCF / Net income | 1.21 | 0.90 | 0.87 | 0.84 | 0.99 | 0.36 | 0.33 | 0.93 | 0.81 | 0.76 | 0.60 | 0.61 | – |
| FCF / OCF | 100.0% | 100.0% | 100.5% | – | 100.0% | 100.0% | 103.0% | 100.0% | – | – | – | – | – |
| FCF / Net income | 1.21 | 0.90 | 0.87 | – | 0.99 | 0.36 | 0.34 | 0.93 | – | – | – | – | – |
| Unlevered free cash flow | -$15.70M | -$24.72M | -$10.85M | – | -$15.14M | -$10.77M | -$7.25M | -$14.45M | – | – | – | – | – |
| Levered free cash flow | -$15.70M | -$24.72M | -$10.85M | – | -$15.14M | -$10.77M | -$7.25M | -$14.45M | – | – | – | – | – |
| Efficiency | |||||||||||||
| CapEx to OCF | -0.01% | -0.03% | -0.46% | – | -0.02% | -0.04% | -3.0% | -0.02% | – | – | – | – | – |
| Liquidity | |||||||||||||
| Current ratio | 1.93 | 1.94 | 3.78 | 2.85 | 7.69 | 2.89 | 6.78 | 17.39 | 2.97 | 6.00 | 0.41 | – | – |
| Quick ratio | 1.93 | 1.94 | 3.78 | 2.85 | 7.69 | 2.89 | 6.78 | 17.39 | 2.97 | 6.00 | 0.41 | – | – |
| Cash ratio | 1.82 | 1.94 | 3.76 | 2.83 | 7.60 | 2.73 | 6.69 | 12.99 | 0.01 | 5.83 | 0.41 | – | – |
| Working capital | $5.23M | $7.80M | $16.55M | $21.75M | $14.43M | $6.99M | $12.04M | $3.59M | $12.62M | $20.63M | -$5.27M | – | – |
| Net current asset value | $5.09M | $7.74M | $16.42M | $21.75M | $14.38M | $6.92M | $11.94M | $3.45M | $3.93M | $20.62M | -$5.27M | – | – |
| Leverage | |||||||||||||
| Assets to equity | 2.09 | 2.05 | 1.37 | 1.54 | 1.15 | 1.52 | 1.18 | -0.29 | 760.68 | 1.20 | -0.36 | – | – |
| Per share | |||||||||||||
| EPS (basic) | -7.35 | -39.13 | -27.06 | -477.62 | -1,743.28 | -4,831.20 | -10,771.20 | -9,636.00 | -23,449.80 | -18,658.20 | -32,960.40 | -1,524.60 | – |
| EPS (diluted) | -7.35 | -39.13 | -27.06 | -477.62 | -1,743.28 | -4,831.20 | -10,771.20 | -9,636.00 | -23,449.80 | -18,658.20 | -32,960.40 | -1,524.60 | – |
| Book value per share | 2.31 | 10.10 | 37.41 | 75.25 | 1,445.39 | 966.72 | 2,081.27 | -6,788.96 | 17.06 | 16,156.62 | -23,899.61 | -2,528.57 | – |
| Tangible book value per share | 2.31 | 10.10 | 37.41 | 75.25 | 1,445.39 | 966.72 | 2,081.27 | -6,788.96 | 17.06 | 16,156.62 | -23,899.61 | -2,528.57 | – |
| Cash per share | 4.45 | 20.40 | 50.30 | 115.43 | 1,622.64 | 1,354.05 | 2,357.43 | 1,453.76 | 34.13 | 18,819.89 | 6,988.42 | 1,509.52 | – |
| Operating cash flow per share | -6.80 | -31.47 | -24.21 | -40.52 | -1,498.56 | -1,444.64 | -1,191.84 | -7,384.26 | -18,362.46 | -8,647.61 | -10,488.42 | -928.57 | – |
| Free cash flow per share | -6.80 | -31.48 | -24.33 | – | -1,498.86 | -1,445.18 | -1,228.07 | -7,385.79 | – | – | – | – | – |
| CapEx per share | 0.0009 | 0.01 | 0.11 | – | 0.30 | 0.54 | 36.23 | 1.53 | – | – | – | – | – |
| Valuation at period end | |||||||||||||
| Market cap | $18.54M | $17.48M | $17.76M | $637.65K | $27.19M | $86.24M | $47.34M | $105.05M | $768.31M | $660.83M | – | – | – |
| Enterprise value | $4.26M | -$4.19M | -$8.08M | -$5.72M | $20.21M | $73.89M | $26.21M | $81.24M | $742.97M | $632.46M | – | – | – |
| P/B | 3.5x | 2.2x | 1.1x | 0.0x | 1.9x | 12.0x | 3.9x | -7.9x | 30,732x | 32.0x | – | – | – |
| P/TBV | 3.5x | 2.2x | 1.1x | 0.0x | 1.9x | 12.0x | 3.9x | -7.9x | 30,732x | 32.0x | – | – | – |
| P/OCF | -1.2x | -0.7x | -1.6x | -0.1x | -1.8x | -8.0x | -6.7x | -7.3x | -28.6x | -59.8x | – | – | – |
| EV/EBIT | – | 0.1x | 0.5x | 0.3x | – | – | – | – | – | – | – | – | – |
| EV/OCF | -0.3x | 0.2x | 0.7x | 0.5x | -1.3x | -6.9x | -3.7x | -5.6x | -27.6x | -57.3x | – | – | – |
| EV/FCF | – | 0.2x | 0.7x | – | – | – | – | – | – | – | – | – | – |
| Earnings yield | -70.0% | -157.9% | -70.2% | -2,190.4% | -56.2% | -34.4% | -45.0% | -14.8% | -4.3% | -2.2% | – | – | – |
| FCF yield | -84.7% | -141.4% | -61.1% | – | -55.7% | -12.5% | -15.3% | -13.8% | – | – | – | – | – |
| Per employee | |||||||||||||
| Total employees | 9 | 9 | 8 | 2 | 5 | 7 | 12 | 9 | 18 | 16 | 16 | 16 | 16 |
| Operating profit per employee | -$1.52M | -$3.20M | -$1.99M | -$9.81M | -$3.06M | -$4.25M | -$1.68M | -$1.72M | -$1.84M | -$918.50K | -$504.75K | -$16.63K | – |
| Net income per employee | -$1.44M | -$3.07M | -$1.56M | -$6.98M | -$3.06M | -$4.24M | -$1.78M | -$1.73M | -$1.86M | -$911.63K | -$564.31K | -$20.00K | – |
| Free cash flow per employee | -$1.74M | -$2.75M | -$1.36M | – | -$3.03M | -$1.54M | -$604.42K | -$1.61M | – | – | – | – | – |
| Growth | |||||||||||||
| EBIT 1Y growth | 52.4% | -81.3% | 19.1% | -28.3% | 48.5% | -47.3% | -30.3% | 53.2% | -125.4% | -82.0% | -2,936.1% | – | – |
| Net income 1Y growth | 53.0% | -121.3% | 10.7% | 8.6% | 48.5% | -39.3% | -37.2% | 53.5% | -129.1% | -61.5% | -2,721.6% | – | – |
| Diluted EPS 1Y growth | 81.2% | -44.6% | 94.3% | 72.6% | 63.9% | 55.1% | -11.8% | 58.9% | -25.7% | 43.4% | -2,061.9% | – | – |
| Operating cash flow 1Y growth | 36.5% | -128.8% | 7.8% | 22.6% | -40.6% | -52.9% | 51.3% | 46.3% | -143.6% | -103.3% | -2,686.2% | – | – |
| Free cash flow 1Y growth | 36.5% | -127.8% | – | – | -40.6% | -48.5% | 49.8% | – | – | – | – | – | – |
| CapEx 1Y growth | -75.0% | -84.0% | – | – | -25.0% | -98.1% | 7,033.3% | – | – | – | – | – | – |
| CapEx 3Y CAGR | – | 38.7% | 132.1% | – | 0.00% | – | – | – | – | – | – | – | – |
| CapEx 5Y CAGR | -12.9% | -48.2% | 75.5% | – | – | – | – | – | – | – | – | – | – |
| Total assets 1Y growth | -31.6% | -28.6% | -32.1% | 99.6% | 53.2% | -24.2% | 278.7% | -79.9% | -23.2% | 451.3% | – | – | – |
| Total assets 3Y CAGR | -30.8% | -1.1% | 27.6% | 32.3% | 63.8% | -16.8% | -16.4% | -5.2% | – | – | – | – | – |
| Total assets 5Y CAGR | 0.28% | 2.4% | 42.9% | 12.0% | -7.5% | 19.6% | – | – | – | – | – | – | – |
| Total assets 10Y CAGR | 9.5% | – | – | – | – | – | – | – | – | – | – | – | – |
| Total equity 1Y growth | -32.8% | -52.5% | -23.3% | 49.0% | 102.7% | -41.4% | 192.5% | -53,244.0% | -99.9% | 266.7% | -2,231.5% | -101.1% | – |
| Total equity 3Y CAGR | -37.4% | -18.4% | 32.3% | 21.0% | – | 560.5% | -15.9% | – | – | – | – | – | – |
| Total equity 5Y CAGR | -5.8% | -8.4% | – | 287.2% | -6.7% | – | – | – | – | – | – | – | – |
Every figure here is calculated from standardized financial statements — hover a row name for the formula — not reported by the company. Valuation multiples use the closing price at the end of that period, not today's price.